ResMed Doubles Down On Connected Care With $800m Brightree Acquisition

Resmed continues its push to integrate healthcare analytics and cloud-based software into its respiratory management devices with its proposed $800m acquisition of Brightree, a developer of cloud-based software for improving clinical and business performance for providers of post-acute care. The move expands ResMed's offerings to its core HME/DME sleep customers and opens doors in new market segments, including home health and hospital channels, where there is a high prevalence of sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases.